Dodge & Cox reports 31.3M GEHC shares (6.9%)

GE HEALTHCARE TECHNOLOGIES INC.

Rhea-AI Filing Summary

GE HEALTHCARE TECHNOLOGIES INC. Schedule 13G/A shows 31,312,064 shares beneficially owned as of 03/31/2026, representing 6.9% of the outstanding common stock. The filing reports 29,686,614 shares as sole voting power and 31,312,064 shares as sole dispositive power.

The disclosure states these holdings are held on behalf of Dodge & Cox clients, including registered investment companies and managed accounts. The form is signed by the firm’s Chief Compliance Officer on 05/14/2026.

Insights

Institutional Ownership Analyst

Large passive holding disclosed: 31.3M shares, 6.9% of GEHC.

Dodge & Cox reports beneficial ownership of 31,312,064 shares with sole voting power over 29,686,614 shares as of 03/31/2026. The filing identifies the positions as held for clients, including investment companies and managed accounts.

Because this is a Schedule 13G/A disclosure of institutional ownership, it reflects a passive investment reporting threshold rather than an active takeover intent; subsequent filings would show material changes in ownership or voting intent.

Key Figures

Beneficially owned shares: 31,312,064 shares Percent of class: 6.9% Sole voting power: 29,686,614 shares

3 metrics

Beneficially owned shares 31,312,064 shares as of 03/31/2026

Percent of class 6.9% percentage of outstanding common stock

Sole voting power 29,686,614 shares shares with sole power to vote

Key Terms

Schedule 13G/A, Beneficial ownership, Sole dispositive power

3 terms

Schedule 13G/A regulatory

"Amendment No. 2; Schedule 13G/A reporting beneficial ownership"

A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.

Beneficial ownership financial

"Amount beneficially owned: 31,312,064 (b) Percent of class: 6.9 %"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

Sole dispositive power financial

"Sole power to dispose or to direct the disposition of: 31,312,064"

Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What stake does Dodge & Cox report in GE HEALTHCARE (GEHC)?

Dodge & Cox reports beneficial ownership of 31,312,064 shares, or 6.9%. The filing states this position is held for Dodge & Cox clients, including registered investment companies and other managed accounts, and lists sole voting and dispositive powers.

As of what date are the Dodge & Cox holdings reported for GEHC?

The holdings are reported as of 03/31/2026. The Schedule 13G/A shows the share counts tied to that date and the form was signed by the Chief Compliance Officer on 05/14/2026.

How much voting power does Dodge & Cox have in GE HEALTHCARE (GEHC)?

Dodge & Cox reports sole voting power over 29,686,614 shares. The filing also shows shared voting power as zero and sole dispositive power equal to the full 31,312,064 shares reported beneficially owned.

Are the Dodge & Cox shares held personally or on behalf of clients?

The filing states the shares are held on behalf of Dodge & Cox clients. It lists clients including investment companies registered under the Investment Company Act of 1940 and other managed accounts as the beneficial recipients of dividends and sale proceeds.

Does the Schedule 13G/A indicate any change in Dodge & Cox’s intent for GEHC shares?

The Schedule 13G/A format indicates passive reporting at the >5% threshold. The filing presents ownership detail but does not state any change in voting intent or plans; no active change-of-control language is included in the excerpt.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/14/2026 - 12:41 PM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 2)

GE HEALTHCARE TECHNOLOGIES INC.

(Name of Issuer)

Common Stock

(Title of Class of Securities)

36266G107

(CUSIP Number)

03/31/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 36266G107

1

Names of Reporting Persons

Dodge & Cox

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

CALIFORNIA

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 29,686,614.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 31,312,064.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

31,312,064.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

6.9 %

12

Type of Reporting Person (See Instructions)

IA

SCHEDULE 13G

Item 1.
(a)	Name of issuer: GE HEALTHCARE TECHNOLOGIES INC.
(b)	Address of issuer's principal executive offices: 500 W. Monroe Street, Chicago, IL 60661
Item 2.
(a)	Name of person filing: Dodge & Cox
(b)	Address or principal business office or, if none, residence: 555 California Street 40th Floor, San Francisco, CA 94104
(c)	Citizenship: California, USA
(d)	Title of class of securities: Common Stock
(e)	CUSIP No.: 36266G107
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 31,312,064
(b)	Percent of class: 6.9 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 29,686,614
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 31,312,064
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required. The clients of Dodge & Cox, including investment companies registered under the Investment Company Act of 1940 and other managed accounts, have the right to receive or power to direct the receipt of dividends from, and the proceeds from the sale of, GE HEALTHCARE TECHNOLOGIES INC.
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Dodge & Cox

Signature:	/S/ Katherine M. Primas
Name/Title:	Chief Compliance Officer
Date:	05/14/2026